Occult Aortic Stenosis As Cause of Intractable Heart Failure
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Cardiac Involvement in COVID-19 Patients: a Contemporary Review
Review Cardiac Involvement in COVID-19 Patients: A Contemporary Review Domenico Maria Carretta 1, Aline Maria Silva 2, Donato D’Agostino 2, Skender Topi 3, Roberto Lovero 4, Ioannis Alexandros Charitos 5,*, Angelika Elzbieta Wegierska 6, Monica Montagnani 7,† and Luigi Santacroce 6,*,† 1 AOU Policlinico Consorziale di Bari-Ospedale Giovanni XXIII, Coronary Unit and Electrophysiology/Pacing Unit, Cardio-Thoracic Department, Policlinico University Hospital of Bari, 70124 Bari, Italy; [email protected] 2 AOU Policlinico Consorziale di Bari-Ospedale Giovanni XXIII, Cardiac Surgery, Policlinico University Hospital of Bari, 70124 Bari, Italy; [email protected] (A.M.S.); [email protected] (D.D.) 3 Department of Clinical Disciplines, School of Technical Medical Sciences, University of Elbasan “A. Xhuvani”, 3001 Elbasan, Albania; [email protected] 4 AOU Policlinico Consorziale di Bari-Ospedale Giovanni XXIII, Clinical Pathology Unit, Policlinico University Hospital of Bari, 70124 Bari, Italy; [email protected] 5 Emergency/Urgent Department, National Poisoning Center, Riuniti University Hospital of Foggia, 71122 Foggia, Italy 6 Department of Interdisciplinary Medicine, Microbiology and Virology Unit, University of Bari “Aldo Moro”, Piazza G. Cesare, 11, 70124 Bari, Italy; [email protected] 7 Department of Biomedical Sciences and Human Oncology—Section of Pharmacology, School of Medicine, University of Bari “Aldo Moro”, Policlinico University Hospital of Bari, p.zza G. Cesare 11, 70124 Bari, Italy; [email protected] * Correspondence: [email protected] (I.A.C.); [email protected] (L.S.) † These authors equally contributed as co-last authors. Citation: Carretta, D.M.; Silva, A.M.; D’Agostino, D.; Topi, S.; Lovero, R.; Charitos, I.A.; Wegierska, A.E.; Abstract: Background: The widely variable clinical manifestations of SARS-CoV2 disease (COVID-19) Montagnani, M.; Santacroce, L. -
Cardiology-EKG Michael Bradley
Cardiology/EKG Board Review Michael J. Bradley D.O. DME/Program Director Family Medicine Residency Objectives • Review general method for EKG interpretation • Review specific points of “data gathering” and “diagnoses” on EKG • Review treatment considerations • Review clinical cases/EKG’s • Board exam considerations EKG EKG – 12 Leads • Anterior Leads - V1, V2, V3, V4 • Inferior Leads – II, III, aVF • Left Lateral Leads – I, aVL, V5, V6 • Right Leads – aVR, V1 11 Step Method for Reading EKG’s • “Data Gathering” – steps 1-4 – 1. Standardization – make sure paper and paper speed is standardized – 2. Heart Rate – 3. Intervals – PR, QT, QRS width – 4. Axis – normal vs. deviation 11 Step Method for Reading EKG’s • “Diagnoses” – 5. Rhythm – 6. Atrioventricular (AV) Block Disturbances – 7. Bundle Branch Block or Hemiblock of – 8. Preexcitation Conduction – 9. Enlargement and Hypertrophy – 10. Coronary Artery Disease – 11. Utter Confusion • The Only EKG Book You’ll Ever Need Malcolm S. Thaler, MD Heart Rate • Regular Rhythms Heart Rate • Irregular Rhythms Intervals • Measure length of PR interval, QT interval, width of P wave, QRS complex QTc • QTc = QT interval corrected for heart rate – Uses Bazett’s Formula or Fridericia’s Formula • Long QT syndrome – inherited or acquired (>75 meds); torsades de ponites/VF; syncope, seizures, sudden death Axis Rhythm • 4 Questions – 1. Are normal P waves present? – 2. Are QRS complexes narrow or wide (≤ or ≥ 0.12)? – 3. What is relationship between P waves and QRS complexes? – 4. Is rhythm regular or irregular? -
Antithrombotic Therapy in Atrial Fibrillation Associated with Valvular Heart Disease
Europace (2017) 0, 1–21 EHRA CONSENSUS DOCUMENT doi:10.1093/europace/eux240 Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulacion Cardıaca y Electrofisiologıa (SOLEACE) Gregory Y. H. Lip1*, Jean Philippe Collet2, Raffaele de Caterina3, Laurent Fauchier4, Deirdre A. Lane5, Torben B. Larsen6, Francisco Marin7, Joao Morais8, Calambur Narasimhan9, Brian Olshansky10, Luc Pierard11, Tatjana Potpara12, Nizal Sarrafzadegan13, Karen Sliwa14, Gonzalo Varela15, Gemma Vilahur16, Thomas Weiss17, Giuseppe Boriani18 and Bianca Rocca19 Document Reviewers: Bulent Gorenek20 (Reviewer Coordinator), Irina Savelieva21, Christian Sticherling22, Gulmira Kudaiberdieva23, Tze-Fan Chao24, Francesco Violi25, Mohan Nair26, Leandro Zimerman27, Jonathan Piccini28, Robert Storey29, Sigrun Halvorsen30, Diana Gorog31, Andrea Rubboli32, Ashley Chin33 and Robert Scott-Millar34 * Corresponding author. Tel/fax: þ44 121 5075503. E-mail address: [email protected] Published on behalf of the European Society of Cardiology. All rights reserved. VC The Author 2017. For permissions, please email: [email protected]. 2 G.Y.H. Lip 1Institute of Cardiovascular Sciences, University of Birmingham and Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Denmark (Chair, representing EHRA); 2Sorbonne Universite´ Paris 6, ACTION Study Group, Institut De Cardiologie, Groupe Hoˆpital Pitie´-Salpetrie`re (APHP), INSERM UMRS 1166, Paris, France; 3Institute of Cardiology, ‘G. -
Mitral Valve Disease in Dogs- Truly Epic Kristin Jacob, DVM, DACVIM CVCA Cardiac Care for Pets Towson, MD
Mitral Valve Disease in Dogs- Truly Epic Kristin Jacob, DVM, DACVIM CVCA Cardiac Care for Pets Towson, MD Chronic degenerative mitral valvular disease (DMVD) is the most common heart disease in dogs. In dogs with congestive heart failure, 75% have mitral regurgitation/degenerative valvular disease. Almost all have tricuspid regurgitations as well, but clinically the mitral regurgitation is the most significant. Degenerative valvular disease is most common in small breed dogs and more common in males than females. DMVD has been proven to be inherited in the Cavalier King Charles Spaniel and the Dachshund but several other breeds are predisposed, such as Bichons, poodles, Chihuahuas, Miniature Schnauzers, Boston Terriers. The cause of degenerative valvular disease remains unknown. However, the valve changes occur due to a destruction of collagen, deposition of mucopolysaccharide in the spongiosa and fibrosa layer of mitral valve, which also affects chordae tendinea. These changes prevent effective coaptation of the valve leaflets leading to progressive mitral regurgitation. Mitral regurgitation (MR) leads to decreasing forward output and increasing left atrial and left ventricular dilation and remodeling as well as activation of the neurohormonal systems. Typically, patients will have 2-3 years in asymptomatic phase (time between when heart murmur detected) until symptoms develop - congestive heart failure (CHF). We can detect progressive heart enlargement 6-12 months prior to the development of CHF. This means that we have a fairly long time period to intervene with therapy and alter the progression of the disease - we know what’s coming! Eventually left atrial pressure increases sufficiently and pulmonary congestion develops leading to symptoms of CHF and can also lead to pulmonary hypertension. -
Parasystole in a Mahaim Accessory Pathway
223 Case Report Parasystole in a Mahaim Accessory Pathway Chandramohan Ramasamy MD, Senthil Kumar MD, Raja J Selvaraj MD, DNB Department of Cardiology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India Address for Correspondence: Dr. Raja J Selvaraj, Assistant Professor of Cardiology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry - 605006, India. E-Mail: [email protected] Abstract Automaticity has been described in Mahaim pathways, both spontaneously and during radiofrequency ablation. We describe an unusual case of automatic rhythm from a Mahaim pathway presenting as parasystole. The parasystolic beats were also found to initiate tachycardia, resulting in initial presentation with incessant tachycardia and tachycardia induced cardiomyopathy. Key words: Mahaim tachycardia, Parasystole, Automaticity Introduction Mahaim pathways are atriofascicular accessory pathways with decremental, anterograde only conduction. The most common clinical manifestation related to these pathways is antidromic reentrant tachycardia. Less commonly, the pathway may be a bystander with atrioventricular nodal reentrant tachycardia or atrial tachycardia. Rarely, automaticity has been reported from the pathway, manifesting as ectopic beats during sinus rhythm or as an automatic tachycardia [1,2]. Parasystole is a condition where an ectopic focus is unaffected by the underlying rhythm due to entrance block. Parasystole has been reported from atrial musculature, ventricular musculature -
Clinical Manifestation and Survival of Patients with I Diopathic Bilateral
ORIGINAL ARTICLE Clinical Manifestation and Survival of Patients with Mizuhiro Arima, TatsujiI diopathicKanoh, Shinya BilateralOkazaki, YoshitakaAtrialIwama,DilatationAkira Yamasaki and Sigeru Matsuda Westudied the histories of eight patients who lacked clear evidence of cardiac abnormalities other than marked bilateral atrial dilatation and atrial fibrillation, which have rarely been dis- cussed in the literature. From the time of their first visit to our hospital, the patients' chest radio- graphs and electrocardiograms showed markedly enlarged cardiac silhouettes and atrial fibrilla- tion, respectively. Each patient's echocardiogram showed a marked bilateral atrial dilatation with almost normal wall motion of both ventricles. In one patient, inflammatory change was demonstrated by cardiac catheterization and endomyocardial biopsy from the right ventricle. Seven of our eight cases were elderly women.Over a long period after the diagnosis of cardiome- galy or arrhythmia, diuretics or digitalis offered good results in the treatment of edema and congestion in these patients. In view of the clinical courses included in the present study, we conclude that this disorder has a good prognosis. (Internal Medicine 38: 112-118, 1999) Key words: cardiomegaly, atrial fibrillation, elder women,good prognosis Introduction echocardiography. The severity of mitral and tricuspid regur- gitation was globally assessed by dividing into three equal parts Idiopathic enlargement of the right atrium was discussed by the distance from the valve orifice. The regurgitant jet was de- Bailey in 1955(1). This disorder may be an unusual congenital tected on color Doppler recording in the four-chamber view malformation. A review of the international literature disclosed and classified into one of the three regions (-: none, +: mild, that although several cases have been discussed since Bailey's ++:moderate, +++: severe). -
Brugada Syndrome Associated to Myocardial Ischemia Sindrome De Brugada Associado a Isquemia Miocárdica
Brugada syndrome associated to Myocardial ischemia Sindrome de Brugada associado a isquemia miocárdica Case of Dr Raimundo Barbosa Barros From Fortaleza - Ceará - Brazil Caro amigo Dr. Andrés Gostaria de ouvir a opinião dos colegas do foro sobre este paciente masculino 56anos internado na emergência do nosso hospital dia 03 de Novembro de 2010. Relata que em abril deste ano foi internado por quadro clínico compatível com angina instável (ECG1). Na ocasião foi submetido à coronariografia que revelou lesão crítica proximal da arteria descendente anterior e lesão de 90% na porção distal da artéria coronária direita. Nesta ocasião realizou angioplastia com colocação de stent apenas na artéria descendente anterior ( ECG2 pós ATC) A artéria coronaria direita não foi abordada. O paciente evoluiu assintomático(ECG3). Em 20/09/2010 realizou cintilografia miocárdica de rotina que resultou normal. No dia 03 de novembro de 2010 procura emergência refirindo ter sofrido episódio de sincope precedido de palpitações rápidas e desconforto torácico atípico.(ECGs 4 e 5). Adicionalmente, informa que 4 horas antes da sua admissão havia apresentado febre (não documentada). Não há relato de episódio prévio semelhante ou história familiar positiva para Morte súbita em familiar jovem de primeiro grau. Dosagem seriada de CK-MB e troponina normais. Qual os diagnósticos ECGs e qual a conduta? Um abraço para todos Raimundo Barbosa Barros Fortaleza Ceará Brasil Dear friend, Dr. Andrés, I would like to know the opinion from the colleagues of the forum about this patient (male, 56 years old), admitted in the ER of our hospital, on November 3rd, 2010. He claims that in April of this year he was admitted with symptoms of unstable angina (ECG1). -
Young Adults. Look for ST Elevation, Tall QRS Voltage, "Fishhook" Deformity at the J Point, and Prominent T Waves
EKG Abnormalities I. Early repolarization abnormality: A. A normal variant. Early repolarization is most often seen in healthy young adults. Look for ST elevation, tall QRS voltage, "fishhook" deformity at the J point, and prominent T waves. ST segment elevation is maximal in leads with tallest R waves. Note high take off of the ST segment in leads V4-6; the ST elevation in V2-3 is generally seen in most normal ECG's; the ST elevation in V2- 6 is concave upwards, another characteristic of this normal variant. Characteristics’ of early repolarization • notching or slurring of the terminal portion of the QRS wave • symmetric concordant T waves of large amplitude • relative temporal stability • most commonly presents in the precordial leads but often associated with it is less pronounced ST segment elevation in the limb leads To differentiate from anterior MI • the initial part of the ST segment is usually flat or convex upward in AMI • reciprocal ST depression may be present in AMI but not in early repolarization • ST segments in early repolarization are usually <2 mm (but have been reported up to 4 mm) To differentiate from pericarditis • the ST changes are more widespread in pericarditis • the T wave is normal in pericarditis • the ratio of the degree of ST elevation (measured using the PR segment as the baseline) to the height of the T wave is greater than 0.25 in V6 in pericarditis. 1 II. Acute Pericarditis: Stage 1 Pericarditis Changes A. Timing 1. Onset: Day 2-3 2. Duration: Up to 2 weeks B. Findings 1. -
'Pseudo'- Syndromes in Cardiology
Blood, Heart and Circulation Review Article ISSN: 2515-091X Review: ‘Pseudo’- syndromes in cardiology Mishra A1, Mishra S2 and Mishra JP2* 1Georgetown University, Washington, DC, USA 2Upstate Cardiology, Summit St, Batavia, New York, USA Abstract The term ‘pseudo’ means ‘false’, ‘pretended’, ‘unreal’, or ‘sham’ and it is likely to be of Greek origin, pseudes means false. There are a number of ‘pseudo’ terms and syndromes that we see in the practice of cardiology. Even though the meaning of pseudo is unreal or sham, however these syndromes are true entities as described below. These terms appear more ‘mimicking’ a diagnosis than being truly ‘sham’! We attempted to put together most of the ‘pseudo’-diagnoses under one heading for reference and convenience. However, every condition cannot be described here in full details and the references are available for further studies. Takotsubo cardiomyopathy (Pseudo acute myocardial • Minimal or no cardiac enzyme elevation. infarction) • No significant ST-elevation (<1 mm). This condition was first described in patients in Japan in 1990 • No pathological Q waves in precordial leads. presenting and mimicking as acute coronary syndrome (ACS) with chest pains, ST changes on ECG and mild cardiac enzyme elevation • Deeply inverted or biphasic T waves in V2-3 or sometimes V4-6. consistent otherwise with acute myocardial infarction (AMI). Imaging These changes seen during pain-free period. studies show LV apical ballooning and therefore being called Takotsubo Similar changes can be seen in the setting of chest pains along cardiomyopathy (meaning “Octopus pot”) However, coronary with above noted criteria, however without having any critical LAD angiography in these patients will at best reveal mild atherosclerosis [1]. -
Avalus™ Pericardial Aortic Surgical Valve System
FACT SHEET Avalus™ Pericardial Aortic Surgical Valve System Aortic stenosis is a common heart problem caused by a narrowing of the heart’s aortic valve due to excessive calcium deposited on the valve leaflets. When the valve narrows, it does not open or close properly, making the heart work harder to pump blood throughout the body. Eventually, this causes the heart to weaken and function poorly, which may lead to heart failure and increased risk for sudden cardiac death. Disease The standard treatment for patients with aortic valve disease is surgical aortic valve Overview: replacement (SAVR). During this procedure, a surgeon will make an incision in the sternum to open the chest and expose the heart. The diseased native valve is then Aortic removed and a new artificial valve is inserted. Once in place, the device is sewn into Stenosis the aorta and takes over the original valve’s function to enable oxygen-rich blood to flow efficiently out of the heart. For patients that are unable to undergo surgical aortic valve replacement, or prefer a minimally-invasive therapy option, an alternative procedure to treat severe aortic stenosis is called transcatheter aortic valve replacement (TAVR). The Avalus Pericardial Aortic Surgical Valve System is a next- generation aortic surgical valve from Medtronic, offering advanced design concepts and unique features for the millions of patients with severe aortic stenosis who are candidates for open- heart surgery. The Avalus Surgical Valve The Avalus valve, made of bovine tissue, is also the only stented surgical aortic valve on the market that is MRI-safe (without restrictions) enabling patients with severe aortic stenosis who have the Avalus valve to undergo screening procedures for potential co-morbidities. -
Heart Failure in Aortic Stenosis — Improving Diagnosis and Treatment Michael R
The new england journal of medicine perspective Heart Failure in Aortic Stenosis — Improving Diagnosis and Treatment Michael R. Zile, M.D., and William H. Gaasch, M.D. The development of heart failure in patients with tional to the stroke volume divided by the square aortic stenosis is associated with a high mortality root of the pressure gradient. Therefore, if the stroke rate — unless aortic-valve replacement is per- volume declines, as it does in some patients with formed. There is an especially high risk of death aortic stenosis in whom heart failure has developed, among patients with aortic stenosis and a decreased there is a proportional decline in the pressure gra- ejection fraction. Before surgery is performed in dient. Under these low-flow conditions, the cal- such patients, initial management must include an culated effective aortic-valve area may indicate the evaluation of the severity of the stenotic lesion and presence of severe aortic stenosis, despite a low the functional state of the left ventricle; in addition, transvalvular pressure gradient. A mean pressure the heart failure must be treated and the patient’s gradient that is less than 30 mm Hg in a patient with condition stabilized. It is possible to pursue both what appears to be severe aortic stenosis (an aortic- of these goals simultaneously with echocardio- valve area of <1 cm2) indicates what is referred to as graphic techniques or cardiac catheterization tech- “low-gradient aortic stenosis.” niques, together with selected pharmacologic in- An example of a low pressure gradient in a pa- terventions. Proper evaluation and treatment require an un- derstanding of the pathophysiology of heart failure ABC in patients with aortic stenosis. -
Abnormal ECG Findings in Athletes Normal ECG
SEATTLE CRITERIA Abnormal ECG findings in athletes These ECG findings are unrelated to regular training or expected physiologic adaptation to exercise, may suggest the presence of pathologic cardiovascular disease, and require further diagnostic evaluation. Abnormal ECG finding Definition T wave inversion > 1 mm in depth in two or more leads V2-V6, II and aVF, or I and aVL (excludes III, aVR, and V1) ST segment depression ≥ 0.5 mm in depth in two or more leads Pathologic Q waves > 3 mm in depth or > 40 ms in duration in two or more leads (except III and aVR) Complete left bundle branch block QRS ≥ 120 ms, predominantly negative QRS complex in lead V1 (QS or rS), and upright monophasic R wave in leads I and V6 Intra-ventricular conduction delay Any QRS duration ≥ 140 ms Left axis deviation -30° to -90° Left atrial enlargement Prolonged P wave duration of > 120 ms in leads I or II with negative portion of the P wave ≥ 1 mm in depth and ≥ 40 ms in duration in lead V1 Right ventricular hypertrophy R-V1 + S-V5 > 10.5 mm and right axis deviation > 120° pattern Ventricular pre-excitation PR interval < 120 ms with a delta wave (slurred upstroke in the QRS complex) and wide QRS (> 120 ms) Long QT interval* QTc ≥ 470 ms (male) QTc ≥ 480 ms (female) QTc ≥ 500 ms (marked QT prolongation) Short QT interval* QTc ≤ 320 ms Brugada-like ECG pattern High take-off and downsloping ST segment elevation followed by a negative T wave in ≥ 2 leads in V1-V3 Profound sinus bradycardia < 30 BPM or sinus pauses ≥ 3 sec Mobitz type II 2° AV block Intermittently non-conducted P waves not preceded by PR prolongation and not followed by PR shortening 3° AV block Complete heart block Atrial tachyarrhythmias Supraventricular tachycardia, atrial fibrillation, atrial flutter Premature ventricular contractions ≥ 2 PVCs per 10 second tracing Ventricular arrhythmias Couplets, triplets, and non-sustained ventricular tachycardia *The QT interval corrected for heart rate is ideally measured with heart rates of 60-90 bpm.